ICH Q9(R1) Quality Risk Management (QRM) Masterclass: How To Transform QRM From A Compliance Activity Into A Strategic, Data-Driven Decision-Making Framework (ONLINE EVENT: June 25, 2026)

(MENAFN- GlobeNewsWire - Nasdaq) The main market opportunities include enhancing QRM systems for modern GMP environments, aligning with evolving regulations, and preparing for digital risk management. This offers strategic value by transforming compliance into data-driven decision-making, improving product availability, and boosting organizational resilience.

Dublin, April 14, 2026 (GLOBE NEWSWIRE) -- The "ICH Q9(R1) Quality Risk Management (QRM) (June 25, 2026)" training has been added to ResearchAndMarkets's offering.

This full-day masterclass goes beyond the fundamentals of ICH Q9(R1) and focuses on how to operationalise the revised guideline in real-world GMP environments.

Participants will learn how to transform QRM from a compliance activity into a strategic, data-driven decision-making framework that strengthens product availability, contamination control, and organisational resilience.

The course blends practical exercises, scenario-based workshops, and interactive simulations to help teams apply the new principles of subjectivity reduction, uncertainty management, proportionality, and lifecycle-integrated risk thinking.

This programme is ideal for organisations seeking to modernise their QRM systems, align with evolving regulatory expectations, and prepare for the digital future of risk management.

Who Should Attend:

This course is designed for a cross-functional pharmaceutical audience - anyone involved in making, reviewing, or approving risk-based decisions in GMP operations.

• Quality Assurance and Quality Control personnel
• Risk owners and decision makers
• Manufacturing & operations leaders
• Process development & validation specialists
• Engineering and Technical Support
• Regulatory Affairs professionals
• Supply Chain and technical operations managers
• Validation, Process Development, and Engineering roles
• Regulatory affairs teams
• Consultants, Auditors, and Service Providers
• Digital transformation and data analytics roles

Key Topics Covered:

• Module 1: The new QRM landscape
• Module 2: Bias, uncertainty & decision quality
• Module 3: Advanced hazard identification
• Module 4: Proportionality & right sizing
• Module 5: Digital QRM & AI enabled risk systems
• Module 6: Building a future ready QRM programme
• Case Study - Risk scoring & risk based decision making

CPD Hours: 6
Speakers

Paul Palmer

Paul R Palmer is a Director / Pharmaceutical Consultant and a practicing EU / UK Qualified Person. He has over 35 years experience in the pharmaceutical industry in the development, manufacture and supply of medicinal products and medical devices.

Throughout his career, Paul has intentionally taken on all opportunities as they arose in order to develop a broad range of knowledge with an in-depth detailed understanding of manufacturing, storage, distribution, research, computerised systems, as well as the facilities and services to support each.

People and systems have always been a core focus, how to ensure best use, optimise and enhance efficiency. He has a level of curiosity rarely displayed in people taking on the qualified person role in pharmaceutical manufacturing. Culture, behaviour and psychology are all significant influences on the systems and processes we implement, but are often ignored.

For more information about this training visit

About is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.

CONTACT: CONTACT: Laura Wood,Senior Press Manager... For E.S.T Office Hours Call 1-917-300-0470 For U.S./ CAN Toll Free Call 1-800-526-8630 For GMT Office Hours Call +353-1-416-8900

MENAFN14042026004107003653ID1110979945